FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine and pharmacology, namely to medications based on peptides. Composition includes 0.01-0.03 mg per one therapeutic dose of endogen interferon inductor - dipeptide of glutamic acid, selected from group, which includes alpha-glutamyl triptophan, gamma-glutamyl triptophan and alpha-lysyl glutamine, Composition also contains co-inductor of endogen interferon - glycyrrhizic acid, taken in form of sodium or ammonium salt in quantity 50-500 mg per one dose.
EFFECT: invention insures formation of prolonged antiviral resistance, necessary for fast and effective elimination of virus-causative agent and elimination of disease symptoms.
3 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION BASED ON HERBAL EXTRACTS FOR TREATMENT AND PREVENTION OF VIRAL INFECTIONS AND SYPHILIS AND METHOD OF TREATMENT AND PREVENTION OF VIRAL INFECTIONS AND SYPHILIS | 2009 |
|
RU2401121C1 |
| TABLETTED PHARMACEUTICAL COMPOSITION FOR TREATING SEVERE FORMS OF VIRAL INFECTIONS | 2014 |
|
RU2559179C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING ENZYME RIBONUCLEASE AND GLYCYRRHIZIC ACID OR SALTS THEREOF: AMMONIUM OR DIPOTASSIUM OR TRISODIUM GLYCYRRHIZINATE | 2012 |
|
RU2504397C1 |
| ANTI-VIRAL IMMUNOTROPIC AGENT FOR TREATMENT OF ARVI | 2018 |
|
RU2672888C1 |
| PHARMACEUTICAL COMPOSITION OF ANTIVIRAL PREPARATION AND METHOD FOR PREVENTION AND TREATMENT OF VIRAL DISEASES BY THIS PREPARATION | 2009 |
|
RU2429875C2 |
| METHODS OF PREVENTION AND TREATMENT OF DISEASES CAUSED BY A/H5N1 BIRD INFLUENZA VIRUS WITH USING INTERFERON INDUCER AND NEURAMINIDASE INHIBITOR | 2008 |
|
RU2398596C2 |
| ANTISTRESS AND NOOTROPIC PREPARATION OF ANTIVIRAL AND IMMUNOSTIMULATING ACTION | 2001 |
|
RU2211703C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF VIRAL DISEASES | 1999 |
|
RU2165254C2 |
| PHARMACEUTICAL COMPOSITION FOR ATOPIC DERMATITIS | 2010 |
|
RU2453303C1 |
| IMMUNOCORRECTIVE AGENT FOR TREATING DISEASES OF VIRAL AETIOLOGY | 2007 |
|
RU2411039C2 |
